BRIEF—Genmab appoints new chief strategy officer

Danish biotech Genmab has appointed Martine van Vugt to the role of chief strategy officer, overseeing corporate strategy, licensing and business development, among other things.

A long-time Genmab employee, Ms van Vugt began her career in scientific and research positions and gained increased responsibility at the company, including with contributions to key partnerships with firms such as Johnson & Johnson, BioNTech and AbbVie.

Chief executive Jan van de Winkel said the firm was “on an exciting and pivotal journey as we deliver on our promise to bring truly innovative antibody medicines to patients.”

He added: “Martine’s skilled approach to corporate strategy and business development has contributed to productive relationships with our partners and to the successful management of our alliances.”